BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2418910)

  • 1. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
    Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
    Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
    Cornish JL; van den Buuse M
    Brain Res; 1995 Dec; 701(1-2):28-38. PubMed ID: 8925292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.
    Eison AS; Eison MS; Iversen SD
    Brain Res; 1982 Apr; 238(1):137-52. PubMed ID: 6177380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-VTA infusions of the substance P analogue, DiMe-C7, and intra-accumbens infusions of amphetamine induce analgesia in the formalin test for tonic pain.
    Altier N; Stewart J
    Brain Res; 1993 Nov; 628(1-2):279-85. PubMed ID: 7508809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area.
    Barnes JM; Barnes NM; Costall B; Cox AJ; Domeney AM; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):839-41. PubMed ID: 1709506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional interaction between the mesolimbic dopamine system and vasopressin release in the regulation of blood pressure in conscious rats.
    Cornish JL; Wilks DP; Van den Buuse M
    Neuroscience; 1997 Nov; 81(1):69-78. PubMed ID: 9300402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions.
    Eison AS; Iversen SD; Sandberg BE; Watson SP; Hanley MR; Iversen LL
    Science; 1982 Jan; 215(4529):188-90. PubMed ID: 6171884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats.
    Placenza FM; Fletcher PJ; Rotzinger S; Vaccarino FJ
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):111-20. PubMed ID: 15167979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P modulation of the mesolimbic dopamine system.
    Kalivas P
    Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats.
    Boix F; Huston JP; Schwarting RK
    Brain Res; 1992 Oct; 592(1-2):181-6. PubMed ID: 1280516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the rat mesolimbic dopamine pathway by neurokinins.
    Elliott PJ; Mason GS; Graham EA; Turpin MP; Hagan RM
    Behav Brain Res; 1992 Oct; 51(1):77-82. PubMed ID: 1282818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic ethanol consumption on the mesolimbic and nigrostriatal dopamine systems.
    Pellegrino SM; Druse MJ
    Alcohol Clin Exp Res; 1992 Apr; 16(2):275-80. PubMed ID: 1534209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones.
    Bannon MJ; Elliott PJ; Alpert JE; Goedert M; Iversen SD; Iversen LL
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):791-2. PubMed ID: 6197656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions.
    Altier N; Stewart J
    Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cardiac baroreflex sensitivity after central dopaminergic stimulation.
    van den Buuse M; Wilks DP; Cornish JL
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):624-6. PubMed ID: 9673440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential effects of caffeine on limbic and cortical dopamine systems.
    Stoner GR; Skirboll LR; Werkman S; Hommer DW
    Biol Psychiatry; 1988 Apr; 23(8):761-8. PubMed ID: 2835113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.